Peptide Therapeutics Targeting Alzheimer’s Disease: An Overview of Aβ Aggregation Inhibitors
Alzheimer’s disease (AD) remains one of the most challenging neurodegenerative disorders worldwide, characterized by progressive cognitive decline and memory impairment. Despite decades of research, therapeutic options are limited, and current treatments primarily provide symptomatic relief without effectively halting or reversing disease progression. A hallmark pathological feature of AD is the extracellular accumulation of amyloid-beta (Aβ) […]